Association between hydrocortisone use and outcomes in sepsis patients with hospital-acquired bloodstream infections: An ancillary analysis of the EUROBACT-2 cohort
Gary Duclos, Mohamed Boucekine, Alexis Tabah, Stéphane Ruckly, Niccolò Buetti, Jean François Timsit, Marc Leone, EUROBACT-2 Study Group · 2026
Read Association between hydrocortisone use and outcomes in sepsis patients with hospital-acquired bloodstream infections: An ancillary analysis of the EUROBACT-2 cohort by Gary Duclos, Mohamed Boucekine, Alexis Tabah, Stéphane Ruckly, Niccolò Buetti, Jean François Timsit, Marc Leone, EUROBACT-2 Study Group (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0356721.txt.
Description
Gary Duclos led a large team, including the EUROBACT-2 Study Group, examining steroid use in sepsis, published in PLOS ONE in 2026. Whether steroids help sepsis patients is one of intensive care's fiercest debates. The team studied patients whose sepsis came with bloodstream infections picked up in hospital, and linked hydrocortisone use to their outcomes.
Duclos's ancillary analysis uses a large existing cohort, adding real-world nuance to trial evidence. It asks when steroids help and when they harm, a question bedside doctors face nightly. Hospital-acquired infections are among the hardest sepsis cases, so evidence in exactly this group is valuable. The study will not end the debate, but it sharpens it with data from real wards.
Catalog record
| CREATOR | Gary Duclos, Mohamed Boucekine, Alexis Tabah, Stéphane Ruckly, Niccolò Buetti, Jean François Timsit, Marc Leone, EUROBACT-2 Study Group |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35885 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |